EMA – Faster access to clinical trial information in Europe

Revised rules for Clinical Trials Information System (CTIS) become applicable

The launch of a new version of the Clinical Trials Information System (CTIS) will allow earlier and more efficient access to information about clinical trials in the European Union (EU) for patients, healthcare professionals and other stakeholders. This is due to the revised transparency rules that become applicable today in Europe.

Read more about this news.

The revised CTIS Transparency rule are applicable on 18 June 2024.

Revised transparency rules apply as of 18 June 2024 for publishing information on clinical trials submitted through CTIS.

The revised rules enable easier access to clinical trial information and ensure a balance between transparency and protection of commercially confidential information.

These changes benefit patients, healthcare professionals and clinical trial sponsors.

More information on the Development of the Clinical Trials Information System on the EMA Website.